CNTB
Connect Biopharma Holdings Ltd. Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website connectbiopharm.com
- Employees(FY) 100
- ISIN US2075231017
Performance
+4.32%
1W
-32.24%
1M
+25.0%
3M
-22.46%
6M
+22.88%
YTD
+22.88%
1Y
Profile
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.
Technical Analysis of CNTB 2024-05-03
Overview:
In analyzing the technical indicators for CNTB over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-05-06 18:30
- 2024-05-02 02:33
- 2024-04-16 04:05
- 2024-03-18 20:30
- 2024-02-12 03:30
- 2023-12-11 17:00
- 2023-12-11 03:05
- 2023-11-29 20:45
- 2023-11-27 20:40
- 2023-11-20 18:32
- 2023-11-20 17:03
- 2023-11-20 17:00
- 2023-11-20 03:41
- 2023-11-05 20:40
- 2023-10-19 21:40
- 2023-09-15 00:00
- 2023-09-12 04:15
- 2023-09-11 18:00
- 2023-08-24 06:21
- 2023-07-09 20:00
- 2023-07-05 04:05
- 2023-06-01 04:05
- 2023-04-11 04:05
- 2023-03-19 21:24
- 2023-03-18 02:40
- 2023-03-17 04:38
Connect Biopharma stock up more than 40% after trial data(Yahoo Finance)
- 2023-03-17 04:05
- 2023-03-05 19:15
- 2023-02-05 19:30
- 2023-01-15 16:13
Page 1 of 3
previousnext